DEVELOPMENT OF A DRUG FOR THE TREATMENT OF CEREBRAL ISCHEMIA WITH ANTI-MIRNA103/107 STRATEGY IN NANOVETTORI- NANOMIRNICTUS (Q4782131)
Jump to navigation
Jump to search
Project Q4782131 in Italy
Language | Label | Description | Also known as |
---|---|---|---|
English | DEVELOPMENT OF A DRUG FOR THE TREATMENT OF CEREBRAL ISCHEMIA WITH ANTI-MIRNA103/107 STRATEGY IN NANOVETTORI- NANOMIRNICTUS |
Project Q4782131 in Italy |
Statements
795,125.88 Euro
0 references
1,096,227.75 Euro
0 references
72.53 percent
0 references
1 January 2017
0 references
30 June 2019
0 references
GENETIC S.P.A.
0 references
BIOTECNOLOGIE (Italian)
0 references
БИОТЕХНОЛОГИЯ (Bulgarian)
0 references
BIOTECHNOLOGIE (Czech)
0 references
BIOTEKNOLOGI (Danish)
0 references
BIOTECHNOLOGIE (German)
0 references
ΒΙΟΤΕΧΝΟΛΟΓΊΑ (Greek)
0 references
BIOTECHNOLOGY (English)
0 references
BIOTECNOLOGÍA (Spanish)
0 references
BIOTEHNOLOOGIA (Estonian)
0 references
BIOTEKNIIKKA (Finnish)
0 references
BIOTECHNOLOGIE (French)
0 references
BITEICNEOLAÍOCHT (Irish)
0 references
BIOTEHNOLOGIJA (Croatian)
0 references
BIOTECHNOLÓGIA (Hungarian)
0 references
BIOTECHNOLOGIJOS (Lithuanian)
0 references
BIOTEHNOLOĢIJA (Latvian)
0 references
BIJOTEKNOLOĠIJA (Maltese)
0 references
BIOTECHNOLOGIE (Dutch)
0 references
BIOTECNOLOGIA (Portuguese)
0 references
BIOTEHNOLOGIE (Romanian)
0 references
BIOTECHNOLÓGIA (Slovak)
0 references
BIOTEHNOLOGIJA (Slovenian)
0 references
BIOTEKNIK (Swedish)
0 references
FISCIANO
0 references
10 April 2023
0 references